DaVita
DVA
#2161
Rank
S$11.20 B
Marketcap
S$156.69
Share price
0.16%
Change (1 day)
-22.82%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): S$13.10

According to DaVita's latest financial reports the company's current EPS (TTM) is S$12.81. In 2024 the company made an earnings per share (EPS) of S$14.22 an increase over its 2023 EPS that were of S$9.81.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$13.10-7.86%
2024S$14.2244.94%
2023S$9.8127.26%
2022S$7.71-35.56%
2021S$11.9644.1%
2020S$8.3019.7%
2019S$6.94540.48%
2018S$1.08-76.07%
2017S$4.52-19.31%
2016S$5.61242.52%
2015S$1.64-62.87%
2014S$4.4113.43%
2013S$3.898.45%
2012S$3.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tenet Healthcare
THC
S$18.95 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
S$2.45-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Universal Health Services
UHS
S$27.52 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$13.21 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA